x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Dr RR Baliga"s "Got Knowledge Doc" Podkast

Dr RR Baliga, MD, MBA

"Got Knowledge Doc" Podkast with Dr. RR Baliga The "Got Knowledge Doc" Podkast, hosted by Dr. Ragavendra R. Baliga, is a knowledge-driven platform designed for physicians and healthcare providers seeking to stay at the forefront of medical science and innovation. With a distinguished career in cardiovascular medicine and academic leadership, Dr. Baliga engages with leading experts to explore cutting-edge research, emerging technologies, and transformative insights in medicine and beyond. Each

science natural sciences

All Episodes

05:44

Chronology vs Physiology: A Clinical Reckoning ⚖️❤️‍🩹

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2026/04/11

🧠⏳ Age. Biology. Truth. A compelling Perspective in the New England Journal of Medicine challenges one of medicine's quiet assumptions: that age equals risk. Two patients may share a birth year—but not a biology. From epigenetic clocks to physiological reserve, the evidence is clear: chronologic age is an imperfect proxy for clinical decision-making ⚠️ The consequence? Missed prevention in the young, withheld therapy in the old. ✨ The opportunity? A shift toward biologically grounded,

en

03:23

The Genetics of GLP-1 Response 🧬💊📊

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2026/04/10

Why do GLP-1 therapies transform some patients—and barely move the needle in others? 🧬💉 A recent Nature study (~28,000 participants) identifies GLP1R and GIPR variants linked to both weight loss efficacy and GI side effects. 📊 Signal: modest for weight loss, stronger for tolerability 🧠 Insight: genetics + clinical factors explain ~25% variability 🚀 Implication: early steps toward precision obesity therapeutics The future may not be "one drug fits all," but one genome, one strategy.

en

06:13

Master Athletes and Cardiovascular Risk

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2026/04/09

Master athletes challenge one of medicine's most elegant assumptions: that fitness always protects. In the Journal of the American College of Cardiology (JACC) consensus statement on athletes with abnormal cardiovascular findings, a paradox emerges—higher fitness, yet distinct patterns of risk: atrial fibrillation, coronary calcium, myocardial fibrosis. The lesson is not to discourage exercise—but to refine our lens. For the clinician: risk stratification must be individualized. For the

en

04:40

Move. Maintain. Multiply: Midlife Activity and...

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2026/04/08

A compelling study in PLOS Medicine: sustained moderate-to-vigorous physical activity across midlife is associated with a ~50% reduction in all-cause mortality in women (target trial emulation). Not intensity, not intermittence—consistency is the signal. For clinicians, the prescription is enduring: move often, move steadily, move for life. 🏃‍♀️💓 #PLOSMedicine #PreventiveCardiology #LifestyleMedicine #HealthyAging

en

02:52

Dhanvantari and the Birth of Ayurveda: Divine...

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2026/04/07

The origins of medicine are not merely scientific—they are deeply philosophical. In our Great Doctors Series, we begin with Dhanvantari, the divine physician of Ayurveda, emerging from myth into method. From the Ocean of Milk to the clinics of today, this episode explores how healing began as a sacred science. For students and physicians alike, it is a reminder that medicine is not just practiced—it is inherited, refined, and reimagined across centuries. 🌿🩺✨ 🎬 "Before medicine became a science,

en

06:10

South Asians and ACS: The SMuRF-less Paradox 🎭🧠💔

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2026/04/06

A fascinating and somewhat unsettling observation from JACC: Asia: nearly 1 in 4 STEMI patients in New Delhi had no traditional risk factors—no hypertension, diabetes, dyslipidemia, or smoking. Yet outcomes tell a different story. Despite fewer signs of heart failure at presentation, these patients had worse left ventricular dysfunction and identical in-hospital and 1-year mortality compared with those with standard risk factors. This "SMuRF-less paradox" challenges our conventional risk models. It

en

10:55

Cardiogenic Shock: 🏥 ICU to Life Again

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2026/04/05

A thoughtful and important JACC State-of-the-Art Review reframes cardiogenic shock not as a single ICU event, but as a longitudinal survivorship journey. The article highlights recovery, remission, native heart survival, PICS, HF GDMT optimization, and the need for structured multidisciplinary postshock clinics focused on function, cognition, quality of life, and recurrent risk after discharge. A timely call to move from rescue alone to rescue plus recovery.

en

05:14

Beyond Aspirin, Clopidogrel Rising: A New Era 💊➡️🧬🚀

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2026/04/04

A landmark 10-year follow-up of the HOST-EXAM trial published in The Lancet challenges a century-old assumption: aspirin may no longer be the default for lifelong secondary prevention after PCI. Clopidogrel demonstrated a sustained reduction in ischemic and bleeding events (HR 0.86, p=0.005), with benefits that accumulated over time—yet without a mortality difference. The implication is subtle but profound: we may be witnessing the quiet reshaping of antiplatelet strategy. In cardiology,

en

04:42

🧠 One Year after Myocardial Infarction: Do...

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2026/04/03

🫀 In the New England Journal of Medicine, the SMART-DECISION trial asks a practical modern question: after myocardial infarction, should stable patients without heart failure or marked left ventricular systolic dysfunction remain on beta-blockers indefinitely? In this randomized noninferiority trial, stopping beta-blockers after at least 1 year was noninferior to continuing them for the composite of death, recurrent myocardial infarction, or hospitalization for heart failure. A provocative study

en

05:48

🎯 Lower. Further. Better: The New LDL Frontier

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2026/04/02

The New England Journal of Medicine has now given us randomized trial evidence for a question long guided more by extrapolation than by direct proof: in patients with established atherosclerotic cardiovascular disease, targeting LDL cholesterol to <55 mg/dL beat a target of <70 mg/dL over 3 years. In Ez-PAVE, the primary end point occurred in 6.6% vs 9.7%, with a hazard ratio of 0.67, supporting a more intensive LDL strategy for secondary prevention. Elegant trial, practical message: when risk is

en

08:44

Nine Rules, Stronger Hearts: 2026 AHA Dietary...

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2026/04/01

New in Circulation: the 2026 AHA Dietary Guidance to Improve Cardiovascular Health distills prevention into 9 elegant features—maintain healthy weight, emphasize vegetables/fruits, choose whole grains, favor healthier proteins and unsaturated fats, minimize ultraprocessed foods, added sugars, and sodium, and avoid starting alcohol for health. Food, here, is not garnish; it is strategy. 🥗🌾🩺 #Cardiology #Preven

en

09:19

Michel Foucault: 1926–1984 • France • historian of...

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2026/03/31

📚 From prisons to clinics to classrooms — what really shapes us? I've been exploring the philosophical work of Michel Foucault, and one idea keeps echoing: 👉 Power isn't just something imposed from above — it quietly operates through systems, language, and everyday norms. From how we define "normal" to how institutions like schools, hospitals, and prisons function, Foucault challenges us to rethink what we take for granted. 🔍 His work invites us to ask: Who defines truth? How do

en

07:23

Left atrial appendage closure—promise meets proof,...

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2026/03/30

Left atrial appendage closure—promise meets proof, and proof meets pause. In The New England Journal of Medicine, two pivotal trials draw a nuanced arc: CHAMPION-AF shows noninferior stroke prevention with less bleeding vs direct oral anticoagulants, while CLOSURE-AF tempers enthusiasm—failing noninferiority in older, high-risk patients with meaningful procedural risk. The message is elegant and sobering: innovation must bow to evidence, and patient selection remains paramount. In atrial

en

05:51

Lower LDL-C earlier, protect longer—the artery...

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2026/03/29

Evolocumab steps into primary prevention—quietly, convincingly. In JAMA, the VESALIUS-CV analysis shows that high-risk patients with diabetes without known atherosclerosis experienced a 31% relative reduction in first MACE (HR 0.69), with LDL-C lowered to ~52 mg/dL. The signal is clear: earlier, deeper lipid lowering matters. Yet questions remain—cost, long-term safety, and who benefits most. Are we ready to treat risk before disease declares itself? 🧠💉📉 #JAMA #Cardiology #Prevention

en

04:21

Rethinking Asymptomatic Aortic Stenosis: Early Knife,...

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2026/03/28

A quiet valve, a loud message. 🫀 The 10-year follow-up of the RECOVERY trial in The New England Journal of Medicine shows that early surgery in asymptomatic very severe aortic stenosis is not premature—it is protective. A striking reduction in cardiovascular mortality (HR 0.10, P=0.002) and sustained divergence of Kaplan–Meier curves challenge the long-held "watchful waiting" paradigm. Perhaps we are not treating symptoms—but preventing myocardial destiny. #Cardiology #AorticStenosis #NEJM

en

04:41

Atheroma Begins Early. Prevention Must Too. See...

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2026/03/27

Cardiology stands at a quiet inflection point. We have spent decades treating plaque—yet the real opportunity lies upstream: preventing atheroma before it begins. Emerging evidence reminds us that cumulative LDL exposure, not just snapshots of risk, shapes lifelong cardiovascular destiny. A shift is underway: → From 10-year risk to lifetime risk → From reactive care to proactive prevention → From treating disease to preserving vascular resilience Lower LDL earlier. Sustain it longer. That is not

en

05:46

Resistant Hypertension: Diagnose, Decode, Defeat 🧩

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2026/03/26

Resistant Hypertension remains one of the most under-recognized yet high-risk phenotypes in cardiovascular medicine. Nearly 1 in 5 treated patients meet criteria for apparent resistance—and up to half may reflect nonadherence or white-coat effect. This concise visual series distills key insights from a recent JAMA review on diagnosis, pathophysiology, and stepwise management—including the pivotal role of spironolactone and emerging therapies like renal denervation. Precision begins with correct

en

03:07

Sound. Mask. Mastery 🎼

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2026/03/25

Sound. Mask. Mastery 🎼 A fascinating insight from C. V. Raman reminds us that hearing is not just perception—it is physics in motion. His 1926 Nature note reveals how lower tones quietly veil higher ones, shaping what we think we hear. In music—and in science—what is hidden often matters most. #Acoustics #CVRaman #Psychoacoustics #SoundScience #NatureJournal

en

03:12

Yajnavalkya: Vedic Sage • Radical Thinker • Timeless...

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2026/03/24

Yajnavalkya: Vedic Sage • Radical Thinker • Timeless Voice 🕉️📜✨ What does it mean to know the Self? Long before modern philosophy, Yajnavalkya in the Brihadaranyaka Upanishad asked—and answered—with striking clarity. "Neti, Neti" (not this, not this) strips illusion, revealing the essence of consciousness—Atman as Brahman. In dialogues with Maitreyi and Gargi, he models fearless inquiry, intellectual rigor, and spiritual depth. Ancient, yet urgent. Subtle, yet transformative.

en

05:03

Nutrition is no longer advice—it is biology, timing,...

Dr RR Baliga"s "Got Knowledge Doc" Podkast ·

2026/03/23

Emerging insights from Nature Spotlight on Nutrition sharpen a simple truth: what we eat matters—but when and how may matter just as much. Morning coffee aligns with lower cardiovascular mortality, plant-forward diets sculpt a favorable microbiome, early-life sugar exposure imprints lifelong risk, and not all potatoes are equal—fried forms carry harm, not the humble baked. Nutrition is no longer advice—it is biology, timing, and destiny intertwined.

en

908 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter